Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
Thyroid Function & Breast Cancer: A Pilot Study to Estimate the Prevalence of Thyroid Dysfunction in Women Diagnosed With Breast Cancer and the Magnitude of Change in Thyroid Function Post-Chemotherapy
Status: Enrolling
Updated:  7/7/2015
Mission Hospitals - Memorial Campus
mi
from
Asheville, NC
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
Thyroid Function & Breast Cancer: A Pilot Study to Estimate the Prevalence of Thyroid Dysfunction in Women Diagnosed With Breast Cancer and the Magnitude of Change in Thyroid Function Post-Chemotherapy
Status: Enrolling
Updated: 7/7/2015
Mission Hospitals - Memorial Campus
mi
from
Asheville, NC
Click here to add this to my saved trials
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
Thyroid Function & Breast Cancer: A Pilot Study to Estimate the Prevalence of Thyroid Dysfunction in Women Diagnosed With Breast Cancer and the Magnitude of Change in Thyroid Function Post-Chemotherapy
Status: Enrolling
Updated:  7/7/2015
Southeastern Medical Oncology Center-Wilson
mi
from
Wilson, NC
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
Thyroid Function & Breast Cancer: A Pilot Study to Estimate the Prevalence of Thyroid Dysfunction in Women Diagnosed With Breast Cancer and the Magnitude of Change in Thyroid Function Post-Chemotherapy
Status: Enrolling
Updated: 7/7/2015
Southeastern Medical Oncology Center-Wilson
mi
from
Wilson, NC
Click here to add this to my saved trials
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
Thyroid Function & Breast Cancer: A Pilot Study to Estimate the Prevalence of Thyroid Dysfunction in Women Diagnosed With Breast Cancer and the Magnitude of Change in Thyroid Function Post-Chemotherapy
Status: Enrolling
Updated:  7/7/2015
Roger Maris Cancer Center at MeritCare Hospital
mi
from
Fargo, ND
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
Thyroid Function & Breast Cancer: A Pilot Study to Estimate the Prevalence of Thyroid Dysfunction in Women Diagnosed With Breast Cancer and the Magnitude of Change in Thyroid Function Post-Chemotherapy
Status: Enrolling
Updated: 7/7/2015
Roger Maris Cancer Center at MeritCare Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
Thyroid Function & Breast Cancer: A Pilot Study to Estimate the Prevalence of Thyroid Dysfunction in Women Diagnosed With Breast Cancer and the Magnitude of Change in Thyroid Function Post-Chemotherapy
Status: Enrolling
Updated:  7/7/2015
AnMed Cancer Center
mi
from
Anderson, SC
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
Thyroid Function & Breast Cancer: A Pilot Study to Estimate the Prevalence of Thyroid Dysfunction in Women Diagnosed With Breast Cancer and the Magnitude of Change in Thyroid Function Post-Chemotherapy
Status: Enrolling
Updated: 7/7/2015
AnMed Cancer Center
mi
from
Anderson, SC
Click here to add this to my saved trials
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
Thyroid Function & Breast Cancer: A Pilot Study to Estimate the Prevalence of Thyroid Dysfunction in Women Diagnosed With Breast Cancer and the Magnitude of Change in Thyroid Function Post-Chemotherapy
Status: Enrolling
Updated:  7/7/2015
CCOP - Scott and White Hospital
mi
from
Temple, TX
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
Thyroid Function & Breast Cancer: A Pilot Study to Estimate the Prevalence of Thyroid Dysfunction in Women Diagnosed With Breast Cancer and the Magnitude of Change in Thyroid Function Post-Chemotherapy
Status: Enrolling
Updated: 7/7/2015
CCOP - Scott and White Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Therapy to Prevent Sexual Pain in Breast Cancer Survivors
Therapy to Prevent Sexual Pain in Menopausal Survivors of Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Oregon Health and Science University
mi
from
Portland, OR
Therapy to Prevent Sexual Pain in Breast Cancer Survivors
Therapy to Prevent Sexual Pain in Menopausal Survivors of Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Wichita
mi
from
Wichita, KA
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Ochsner
mi
from
New Orleans, LA
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Ochsner
mi
from
New Orleans, LA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Duluth
mi
from
Duluth, MN
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Medcenter One Health System
mi
from
Bismarck, ND
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Altru Health Systems
mi
from
Grand Forks, ND
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Altru Health Systems
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Allan Blair Cancer Centre
mi
from
Regina,
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Allan Blair Cancer Centre
mi
from
Regina,
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
Randomized Phase II Study of Adriamycin/Cytoxan/Taxol (ACT) vs. Cytoxan, Thiotepa, Carboplatin (STAMP V) in Patients With High-Risk Primary Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Banner Good Samaritan Medical Center
mi
from
Phoenix, AZ
Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
Randomized Phase II Study of Adriamycin/Cytoxan/Taxol (ACT) vs. Cytoxan, Thiotepa, Carboplatin (STAMP V) in Patients With High-Risk Primary Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Banner Good Samaritan Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
Randomized Phase II Study of Adriamycin/Cytoxan/Taxol (ACT) vs. Cytoxan, Thiotepa, Carboplatin (STAMP V) in Patients With High-Risk Primary Breast Cancer
Status: Enrolling
Updated:  7/7/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
Randomized Phase II Study of Adriamycin/Cytoxan/Taxol (ACT) vs. Cytoxan, Thiotepa, Carboplatin (STAMP V) in Patients With High-Risk Primary Breast Cancer
Status: Enrolling
Updated: 7/7/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Wichita
mi
from
Wichita, KA
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Medcenter One Health System
mi
from
Bismarck, ND
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Click here to add this to my saved trials
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated:  7/7/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated: 7/7/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated:  7/7/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated: 7/7/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated:  7/7/2015
MBCCOP - Medical College of Georgia Cancer Center
mi
from
Augusta, GA
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated: 7/7/2015
MBCCOP - Medical College of Georgia Cancer Center
mi
from
Augusta, GA
Click here to add this to my saved trials
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated:  7/7/2015
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated: 7/7/2015
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Click here to add this to my saved trials
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated:  7/7/2015
St. Joseph Medical Center
mi
from
Bloomington, IL
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated: 7/7/2015
St. Joseph Medical Center
mi
from
Bloomington, IL
Click here to add this to my saved trials
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated:  7/7/2015
Graham Hospital
mi
from
Canton, IL
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated: 7/7/2015
Graham Hospital
mi
from
Canton, IL
Click here to add this to my saved trials
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated:  7/7/2015
Memorial Hospital
mi
from
Carthage, IL
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone
Status: Enrolling
Updated: 7/7/2015
Memorial Hospital
mi
from
Carthage, IL
Click here to add this to my saved trials